摘要
为了了解在高海拔地区使用尿激酶静脉内溶栓治疗急性心肌梗塞（AMI）的效果。回顾性分析了1989～1996年6月间在我院心内科和急诊科接受尿激酶（UK）静脉内溶栓治疗的73例AMI者的临床资料。治疗结果显示：溶栓后再灌注率为49．3％（36／73），再灌注患者并发症的发生本及住院病死率明显低于血管来再道者（P＜0．05）。说明UK对高原地区的AMI也有较好疗效。
In order to understand the effect of thrombolytic therapy by urokinase in acute myocardial infarct(AMI)at high altitude, the clinical data of 73 cases with AMI were reviewed. These cases were all treated by urokinase from 1989 to Jun. 1996. Based on our results of study, it were showed that the reperfusive rate was 49. 3% (36/73)during post-thrombolysis,the complications and mortality in reperfusion group were lower than that in unreperfusion(P<0. 05) to indicate the urokinase have better thrombolytic effect for AMI patients who Iived in altitude.
出处
《高原医学杂志》
CAS
1997年第1期24-26,共3页
Journal of High Altitude Medicine
关键词
心肌梗塞
高原
尿激酶
血栓溶解疗法
Altitude
Myocardiac infarct
Urokinase
Thrombolysis
Therapy
